Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Loss of expression of neutrophil proteinase-3: a contributory factor in thrombotic risk in paroxysmal nocturnal hemoglobinuria.

    ... proteinase 3 levels, clone size and history of thrombosis . In addition, we found that treating platelets ex vivo with ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Self-injected PNH therapy on the horizon

    ... well, which could help in preventing potentially fatal thrombosis among PNH patients. Soliris reduces thrombotic events, but maybe ...

    Article last updated 07/07/2016 - 9:40am.

  3. Decreased plasma cytokines associate with low platelet counts in aplastic anemia and immune thrombocytopenic purpura

    ... platelet disorders. © 2012 International Society on Thrombosis and Haemostasis. ...

    Research Article last updated 07/30/2012 - 1:53pm.

  4. Antonio Maria Risitano, MD, PhD

    ... Pathophysiology , Clinical Manifestations (including Thrombosis ) and Response to Eculizamab PNH Foundation." We recently ...

    Bio last updated 10/20/2017 - 9:50am.

  5. Symptoms

    ... Thrombosis Thrombosis is a blood clot in a vein. It is often simply called a ...

    Topic section last updated 03/29/2016 - 6:18pm.

  6. Foundation Update - July 2016

    ... • PNH: Secondary Mutations and Thrombosis • Transitioning from Pediatric to Adult ...

    Article last updated 10/09/2017 - 2:53pm.

  7. Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux

    Journal Title:  Leuk Res. Primary Author:  Cheng KL Author(s):  Cheng KL, Br...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Research and Education Council

    ... of bone marrow failure conditions (e.g., blood clotting/ thrombosis in PNH, iron overload in MDS, etc). Members ...

    Page last updated 06/20/2017 - 9:22am.

  9. Patrizia Ricci, PhD

    ... ), poor functioning of bone marrow , and thrombosis . Recently, the availability of the complement inhibitor ...

    Grant Recipient last updated 09/14/2016 - 2:42pm.

  10. Robert A. Brodsky, MD

    ... antibody eculizimab was developed to combat the thrombosis that constitutes a leading cause of death in PNH, but produces a ...

    Bio last updated 09/12/2016 - 11:04am.